Another strategy of treating FOP was identified for rapamycin (mTOR) inhibitors or hypoxia-inducible factor 1-Alpha (HIF-1α) inhibitors which reduced the production of HO in FOP mouse models [42,43]. This evidence concerns the gene HIF1A and fibrodysplasia ossificans progressiva.